QPS LLC

Newark, DE Part of QPS Holdings LLC

UEI
P2F8FYL11D41
CAGE
3PVG7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

FY2025 rankings
Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Asian-Pacific American Owned
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
Corporate family
SAM.gov registration date
Physical address
Innovation Way, Newark, DE 19711, USA
Website
qps.com
Founded
1995
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
SIC code
87 Engineering & Management Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 -$57,208
FY2025 $25,900
FY2024 $83,600

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Contract subawards

Prime contractor Prime award Amount Awarded
New TECH Solutions, Inc. NON-GLP DOSE-RANGE FINDING AND GLP TOXICITY STUDIES IN MINIPIGS AND IN VITRO DRUG-DRUG INTERACTION STUDIES FOR A SMALL PEPTIDE Non GLP Dose Range Finding and… 75N95024F00002 $67,760

Similar vendors

About the company

QPS LLC is a minority-owned limited liability company located in Newark, Delaware, registered in the System for Award Management (SAM) since 2004. The company specializes in biotechnology research services, with a focus on advanced laboratory testing, pharmacokinetic studies, and analytical methods development. As a for-profit organization recognized as an Asian-Pacific American owned business, QPS LLC has established itself as a key provider of scientific research services to federal health and research agencies.

The company has been awarded multiple federal contracts primarily from prominent National Institutes of Health (NIH) components, including the National Heart Lung and Blood Institute (NHLBI), National Institute of Neurological Disorders and Stroke (NINDS), and National Center for Advancing Translational Sciences (NCATS). These contracts consistently involve sophisticated scientific services such as LC-MS/MS method development, sample analysis, and pharmacokinetic testing across various research domains. Recent contracts include COVID-19 related bioanalytical testing for remdesivir compounds, non-human primate research on bacterial sepsis, rodent pharmacokinetic testing for the HEAL initiative addressing the opioid crisis, and laboratory testing of specific compounds in monkey plasma samples. The contracts have ranged from $18,600 to $98,000, and have been competitively awarded without small business set-aside designations. Additionally, QPS LLC has participated in federal research efforts as a sub-contractor, such as a sub-award with Battelle Memorial Institute for non-GLP dose range finding and GLP toxicity studies, demonstrating its versatility in supporting complex scientific research initiatives.

Quick answers

Is QPS LLC registered in SAM.gov?

Yes. QPS LLC's SAM.gov registration is active through July 20, 2027.

How much has QPS LLC received in federal contracts?

Federal contracts obligated $25,900 to QPS LLC in fiscal year 2025 and $52,292 in fiscal years 2023 through 2027.

How does QPS LLC rank among federal contractors?

QPS LLC ranked #56 in PSC B504 in FY2025.

What is QPS LLC's most recent federal award?

QPS LLC's most recent federal contract award is Evaluation of R406 levels in a non-human primate model of bacterial sepsis (75N92025P00084), from National Heart Lung and Blood Institute (NIH), on March 6, 2025.

On GovTribe

See QPS LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors